Correction: GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway

Affiliations

• ¹ Division of Cellular Signaling, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
• ² Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
• ³ Laboratory of Genome Stability Maintenance, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
• ⁴ Department of Musculoskeletal Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
• ⁵ Department of Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
• ⁶ Department of Diagnostic Pathology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
• ⁷ Division of Cellular Signaling, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan. [email protected].